Irritable Bowel Syndrome (IBS) Treatment Market – Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Irritable Bowel Syndrome (IBS) Treatment Market Be Worth By 2029?
The market size for irritable bowel syndrome (ibs) treatment has seen significant growth over the past few years. The rise is expected to continue, with the market size set to increase from $2.79 billion in 2024 to $3.06 billion in 2025, indicating a compound annual growth rate (CAGR) of 9.8%. Several factors have driven this growth in the historical period, including an increased incidence of IBS, heightened patient awareness, lifestyle and stress-related influences, the establishment of patient advocacy and support groups, and favorable healthcare reimbursement policies.
The market for irritable bowel syndrome (ibs) treatment is set for considerable expansion in the coming years. Its value is projected to increase to $4.9 billion by 2029, experiencing a compound annual growth rate (CAGR) of 12.5%. The growth during this projected period can be linked to the implementation of healthcare models that focus on patients, the advent of microbial therapies, incorporation of blockchain technology in healthcare, referencing patient outcomes (pros), fast-track programs by regulatory bodies, and health data interoperability. Within this same period, major trends to be observed include the merger of digital health solutions, improvements in diagnostic technologies, an uptick in research and development funding, the forging of collaborations and partnerships, and the rise of non-pharmacological therapies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11978&type=smp
What External And Internal Drivers Are Influencing The Irritable Bowel Syndrome (IBS) Treatment Market?
The escalation of irritable bowel syndrome (IBS) cases is predicted to stimulate the expansion of the IBS treatment market in the near future. IBS, a persistent gastrointestinal disease impacting the large intestine (colon), has been increasing due to factors such as substandard lifestyles, unhealthy eating behaviors, exposure to pollution, and elevated stress levels. IBS treatment assists in mitigating the intensity and regularity of IBS symptoms, enhance life quality, and provides individuals the ability to better deal with their conditions. For example, the International Foundation for Gastrointestinal Disorders (IFFGD), an American non-profit education and research entity, states that about 5–10% of the worldwide populace was suffering from IBS in 2023 and somewhere between 25 and 45 million individuals in the United States are affected by IBS. As such, the proliferation of irritable bowel syndrome (IBS) cases, is fueling the expansion of the IBS treatment market.
What Segmentation Insights Are Provided In The Irritable Bowel Syndrome (IBS) Treatment Market Research?
The irritable bowel syndrome (ibs) treatmentmarket covered in this report is segmented –
1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs
2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Users: Hospitals, Clinics, Homecare Settings
Subsegments:
1) By Lubiprostone: Chronic Idiopathic Constipation Treatment; Irritable Bowel Syndrome with Constipation (IBS-C) Treatment
2) By Linaclotide: IBS-C Treatment; Chronic Idiopathic Constipation Treatment
3) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment
4) By Rifaximin: IBS-D Treatment; Small Intestinal Bacterial Overgrowth (SIBO) Treatment
5) By Alosetron: Severe IBS-D Treatment for Women
6) By Other Drugs: Prucalopride; Tenapanor; Plecanatide
Which Market Trends Are Expected To Define The Future Of The Irritable Bowel Syndrome (IBS) Treatment Market?
Product innovation is emerging as a significant trend in the irritable bowel syndrome (IBS) market, with major players focusing on developing cutting-edge products to solidify their market standing. For example, in April 2022, US-based biotech firm Ardelyx introduced IBSRELA, a pioneering treatment for adult IBS-C. This is the first and sole NHE3 inhibitor for treating adult IBS with constipation (IBS-C). IBSRELA is Ardelyx’s first medicine to receive FDA approval and the first new mechanism therapy for IBS-C to be developed in nearly a decade. This offers a crucial new treatment alternative for constipation, bloating, and stomach ache – symptoms of this debilitating ailment.
Who Are The Leading Companies Driving The Irritable Bowel Syndrome (IBS) Treatment Market?
Major companies operating in the irritable bowel syndrome (IBS) treatment market include Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Cosmo Technologies Ltd., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc.
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Irritable Bowel Syndrome (IBS) Treatment Market?
North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (IBS) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=11978&type=smp
Browse Through More Reports Similar to the Global Irritable Bowel Syndrome (IBS) Treatment Market 2025, By The Business Research Company
Aerospace Composites Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aerospace-composites-global-market-report
Aerospace Fasteners Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aerospace-fasteners-global-market-report
Aerospace Foams Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aerospace-foams-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
